280 related articles for article (PubMed ID: 12208376)
1. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.
Park YB; Choi HK; Kim MY; Lee WK; Song J; Kim DK; Lee SK
Am J Med; 2002 Aug; 113(3):188-93. PubMed ID: 12208376
[TBL] [Abstract][Full Text] [Related]
2. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
[TBL] [Abstract][Full Text] [Related]
3. Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.
Taylor PC; Kremer JM; Emery P; Zuckerman SH; Ruotolo G; Zhong J; Chen L; Witt S; Saifan C; Kurzawa M; Otvos JD; Connelly MA; Macias WL; Schlichting DE; Rooney TP; de Bono S; McInnes IB
Ann Rheum Dis; 2018 Jul; 77(7):988-995. PubMed ID: 29463520
[TBL] [Abstract][Full Text] [Related]
4. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
Navarro-Millán I; Charles-Schoeman C; Yang S; Bathon JM; Bridges SL; Chen L; Cofield SS; Dell'Italia LJ; Moreland LW; O'Dell JR; Paulus HE; Curtis JR
Arthritis Rheum; 2013 Jun; 65(6):1430-8. PubMed ID: 23460074
[TBL] [Abstract][Full Text] [Related]
5. Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis.
Kremer JM; Genovese MC; Keystone E; Taylor PC; Zuckerman SH; Ruotolo G; Schlichting DE; Crotzer VL; Nantz E; Beattie SD; Macias WL
Arthritis Rheumatol; 2017 May; 69(5):943-952. PubMed ID: 28029752
[TBL] [Abstract][Full Text] [Related]
6. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
8. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
Dahlqvist SR; Engstrand S; Berglin E; Johnson O
Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
[TBL] [Abstract][Full Text] [Related]
9. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
[TBL] [Abstract][Full Text] [Related]
10. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study.
Georgiadis AN; Papavasiliou EC; Lourida ES; Alamanos Y; Kostara C; Tselepis AD; Drosos AA
Arthritis Res Ther; 2006; 8(3):R82. PubMed ID: 16646989
[TBL] [Abstract][Full Text] [Related]
11. Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
Choi HK; Seeger JD
J Rheumatol; 2005 Dec; 32(12):2311-6. PubMed ID: 16331755
[TBL] [Abstract][Full Text] [Related]
12. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
[TBL] [Abstract][Full Text] [Related]
13. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
[TBL] [Abstract][Full Text] [Related]
15. Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
Qiu C; Zhao X; She L; Shi Z; Deng Z; Tan L; Tu X; Jiang S; Tang B
Lipids Health Dis; 2019 Feb; 18(1):54. PubMed ID: 30777075
[TBL] [Abstract][Full Text] [Related]
16. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
Filippatos TD; Derdemezis CS; Voulgari PV; Tsimihodimos V; Elisaf MS; Tselepis AD; Drosos AA
Scand J Rheumatol; 2013; 42(3):169-75. PubMed ID: 23311768
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
[TBL] [Abstract][Full Text] [Related]
18. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.
Dursunoğlu D; Evrengül H; Polat B; Tanriverdi H; Cobankara V; Kaftan A; Kiliç M
Rheumatol Int; 2005 May; 25(4):241-5. PubMed ID: 15290086
[TBL] [Abstract][Full Text] [Related]
19. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
Robertson J; Porter D; Sattar N; Packard CJ; Caslake M; McInnes I; McCarey D
Ann Rheum Dis; 2017 Nov; 76(11):1949-1952. PubMed ID: 28916714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
